G. Barbieri

发表

Effects of two organotin(IV)(sulfonatophenyl)porphinates on MAPKs and on the growth of A375 human melanoma cells.

M. A. Costa, L. Gulino, L. Pellerito, 2009, Oncology reports.

The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction.

C. Schindler, O. Silvennoinen, G. Barbieri, 1993, Nature.

Negative Regulation of β Enolase Gene Transcription in Embryonic Muscle Is Dependent upon a Zinc Finger Factor That Binds to the G-rich Box within the Muscle-specific Enhancer*

G. Barbieri, G. Cossu, R. Passantino, 1998, The Journal of Biological Chemistry.

Supramolecular assemblies based on complexes of nonionic amphiphilic cyclodextrins and a meso-tetra(4-sulfonatophenyl)porphine tributyltin(IV) derivative: potential nanotherapeutics against melanoma.

F. Crea, F. Zito, L. Pellerito, 2013, Biomacromolecules.

The HLA-DR mediated signalling increases the migration and invasion of melanoma cells, the expression and lipid raft recruitment of adhesion receptors, PD-L1 and signal transduction proteins.

G. Barbieri, F. Costantini, 2017, Cellular signalling.

MHC class II-deficient tumor cell lines with a defective expression of the class II transactivator.

M. Fellous, G. Barbieri, D. Charron, 2002, International immunology.

Effects of human leukocyte antigen (HLA)-DR engagement on melanoma cells.

G. Barbieri, M. Costa, E. Rimini, 2011, International journal of oncology.

Activation of the protein tyrosine kinase tyk2 by interferon alpha/beta.

M. Fellous, G. Barbieri, L. Velazquez, 1994, European journal of biochemistry.

Structural features of the human gene for muscle-specific enolase. Differential splicing in the 5'-untranslated sequence generates two forms of mRNA.

G. Barbieri, A. Giallongo, S. Feo, 1993, European journal of biochemistry.

Structure of the human gene for alpha-enolase.

G. Barbieri, G. Barba, A. Giallongo, 1990, European journal of biochemistry.

Differential expression of muscle-specific enolase in embryonic and fetal myogenic cells during mouse development.

L. De Angelis, G. Barbieri, G. Cossu, 1990, Differentiation; research in biological diversity.

The Odyssey of Hsp60 from Tumor Cells to Other Destinations Includes Plasma Membrane-Associated Stages and Golgi and Exosomal Protein-Trafficking Modalities

F. Bucchieri, A. Fucarino, F. Farina, 2012, PloS one.

The gene for the muscle-specific enolase is on the short arm of human chromosome 17.

M. Fried, G. Barbieri, A. Giallongo, 1990, Genomics.

Defective class II transactivator expression in a B lymphoma cell line

B. Drénou, C. Bastard, W. Wiszniewski, 2004, Leukemia.

Significance of the endoplasmic reticulum membranes for protein biosynthesis in rat liver and Yoshida hepatoma ascites cells.

G. Barbieri, A. D. Di Marco, 1963, Experimental cell research.

Apoptosis and cell growth arrest in A375 human melanoma cells by diorganotin(IV) and triorganotin(IV) complexes of [meso-Tetra(4-sulfonatophenyl)porphine] manganese(III)chloride.

F. Zito, M. A. Costa, L. Pellerito, 2011, International journal of oncology.

The amino-terminal region of Tyk2 sustains the level of interferon a receptor 1, a component of the interferon ayb receptor

M. Fellous, G. Barbieri, S. Pellegrini, 1997 .

Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course

G. Barbieri, D. Charron, S. Pollack, 2003, Immunogenetics.

Diorganotin(IV) and triorganotin(IV) complexes of meso-tetra(4-sulfonatophenyl)porphine induce apoptosis in A375 human melanoma cells.

M. A. Costa, L. Pellerito, T. Fiore, 2006, Cancer letters.

Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.

G. Yancopoulos, O. Silvennoinen, J. Ihle, 1994, Science.

Transcription of the human beta enolase gene (ENO-3) is regulated by an intronic muscle-specific enhancer that binds myocyte-specific enhancer factor 2 proteins and ubiquitous G-rich-box binding factors

G. Barbieri, R. Passantino, A. Giallongo, 1995, Molecular and cellular biology.

The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction

G. Stark, C. Schindler, O. Silvennoinen, 1993, Nature.

The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor.

M. Fellous, G. Barbieri, S. Pellegrini, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Mutation in the Class II trans-Activator Leading to a Mild Immunodeficiency1

N. Brousse, W. Wiszniewski, G. Barbieri, 2001, The Journal of Immunology.

Structure of the human gene for α‐enolase

G. Barbieri, G. Barba, A. Giallongo, 1990 .

Cloning, expression and sequence homologies of cDNA for human gamma enolase.

G. Barbieri, G. Barba, A. Giallongo, 1989, Gene.

The Hydroxytyrosol Induces the Death for Apoptosis of Human Melanoma Cells

G. Barbieri, C. Di Sano, F. Costantini, 2020, International journal of molecular sciences.

High-dose Ionizing Radiation Regulates Gene Expression Changes in the MCF7 Breast Cancer Cell Line.

G. Russo, M. Gilardi, C. Messa, 2015, Anticancer research.

Dibutyltin(IV) and Tributyltin(IV) Derivatives of meso-Tetra(4-sulfonatophenyl)porphine Inhibit the Growth and the Migration of Human Melanoma Cells

T. Fiore, C. Pellerito, G. Barbieri, 2019, Cells.

Constitutive Expression of MHC Class II Genes in Melanoma Cell Lines Results from the Transcription of Class II Transactivator Abnormally Initiated from Its B Cell-Specific Promoter1

J. Ting, G. Barbieri, D. Charron, 2001, The Journal of Immunology.

Abnormally Initiated from Its B Cell-Specific the Transcription of Class II Transactivator Genes in Melanoma Cell Lines Results from Constitutive Expression of MHC Class II

J. Ting, G. Barbieri, D. Charron, 2001 .

Isoforms of the class II transactivator protein.

A. Fischer, G. Barbieri, D. Charron, 2002, International immunology.

Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency

Dominique Charron, Capucine Picard, A. Fischer, 2002, Immunogenetics.

Erratum: Mutation in the class II trans-activator leading to a mild immunodeficiency (The Journal of Immunology (2001) 167 (1787-1794))

A. Fischer, F. Deist, N. Brousse, 2002 .